Welcome to the Texas Resource Guide
As the only state agency tasked by the Legislature to fund life science innovation in cancer research and prevention, CPRIT has created the Texas Resource Guide to help those ready to innovate in Texas. This online resource provides information about service providers and other entities – including potential sources of investment – that support early stage and developing life science companies in Texas.
CPRIT will update the Texas Resource Guide regularly. If you would like to add your company or organization to the guide, please use the “Add Listing” button at the top of this site to complete a request.
If you have any questions, you can reach CPRIT Product Development Research staff through the information listed under “Contact Us.”
A Word from the CEO
Dear Friends,
At its inception in 2007, the Cancer Prevention and Research Institute of Texas (CPRIT) became the second largest public funder of cancer research in the nation. Created with overwhelming bipartisan support from the Texas Legislature and adopted and reaffirmed by the people of Texas in two statewide votes, CPRIT may invest up to $6 billion to support groundbreaking research into preventing, diagnosing, treating, and surviving cancer.
Understanding that cancer research is most valuable when scientists can translate promising discoveries into safe and reliable drugs, diagnostics, and therapies to treat cancer patients, CPRIT began its Product Development Research program in 2010. To date, CPRIT has committed more than $600 million to identify, develop and fund innovative approaches at Texas-based companies during the crucial early stages of regulatory development. A life science boom now exists in Texas, and we expect to increase CPRIT-funded companies substantially over the next several years.
The Texas Resource Guide is intended to help those companies ready to innovate in Texas, whether they are already here or willing to relocate. The guide provides information about service providers and other entities – including potential sources of investment – that support early stage and developing life science companies in Texas. We will regularly update the guide as additional information becomes available.
Thanks in large part to the sizable and diverse network of vendors, accelerators, co-working offices and wet lab space, biomedical manufacturing, and venture funding, Texas has the resources, the will, and a strong, bipartisan track record for implementing bold approaches to addressing health research and technology challenges.
On behalf of CPRIT, I look forward to working with you to determine how CPRIT can help develop the products necessary to fight cancer and lessen the burden of this disease for all Texans. Together, in many ways, Texans Conquer Cancer.
Sincerely,
Wayne R. Roberts